Build a lasting personal brand

FAQ: BOC Sciences Webinar on Vascular Nano-Delivery with Dr. Muzykantov

By NewsRamp Editorial Team

TL;DR

BOC Sciences' webinar with Dr. Muzykantov reveals advanced vascular targeting strategies that could provide pharmaceutical companies with competitive advantages in developing more effective drug delivery systems.

The webinar explains how vascular nanomedicine works through cognizant targeting using known binding sites and fortuitous tropism where delivery systems exhibit unexpected homing behaviors to specific vascular targets.

This research advances precision medicine by improving drug delivery efficiency, potentially leading to safer, more effective treatments that enhance patient outcomes and quality of life worldwide.

Discover how fortuitous tropism allows drug delivery systems to unexpectedly home in on vascular targets, revealing nature's surprising pathways for precision medicine breakthroughs.

Found this article helpful?

Share it with your network and spread the knowledge!

FAQ: BOC Sciences Webinar on Vascular Nano-Delivery with Dr. Muzykantov

The webinar, titled "Vascular Nano-Delivery Using Tropism and Targeting," focuses on current knowledge of vascular nanomedicine and how drug delivery systems can be optimized to reach specific vascular targets.

Dr. Muzykantov is the Founding Co-Director of the PSOM/SEAS Center for Targeted Therapeutics and Translational Nanomedicine (CT3N) at the University of Pennsylvania, an author of over 330 publications with an h-index of 87, and is widely recognized as a foundational figure in vascular targeting therapies.

The webinar will be held on December 12th, 2025 at 10:00 AM EST as a virtual Zoom meeting.

The webinar will cover both cognizant targeting (based on known binding sites) and fortuitous tropism (where delivery systems exhibit unexpected affinity or "homing" behaviors).

This session addresses one of the most pressing hurdles in pharmaceutical research today: achieving efficient and precise drug delivery, which is crucial for improving drug bioavailability, safety, stability, and effectiveness.

You can register online through the provided link: Online registration here

As a leading drug discovery CDMO, BOC Sciences offers comprehensive solutions for designing, developing, and enhancing delivery systems, with expertise in advanced delivery carriers including liposomes, nanoparticles, and microspheres.

BOC Sciences is a supplier of premium chemicals, biochemicals, and drug discovery solutions that serves researchers and pharmaceutical companies globally, facilitating knowledge-sharing with leading scientific minds to accelerate scientific discovery and therapeutic development.

Any interested professionals in pharmaceutical research, drug delivery systems, or nanomedicine are invited to join the session to connect with insights that will impact the future of drug delivery research.

Curated from 24-7 Press Release

blockchain registration record for this content
NewsRamp Editorial Team

NewsRamp Editorial Team

@newsramp

NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.